1
|
Daif S, El Berbri I, Lhor Y, Fassi Fihri O. Serological and molecular prevalence study of bluetongue virus in small domestic ruminants in Morocco. Sci Rep 2022; 12:19448. [PMID: 36376352 PMCID: PMC9663439 DOI: 10.1038/s41598-022-24067-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Accepted: 11/09/2022] [Indexed: 11/16/2022] Open
Abstract
Bluetongue is an arthropod-borne viral disease transmitted by Culicoides biting midges, affecting domestic and wild ruminants. The current study aims to assess the seroprevalence of the bluetongue virus (BTV) and confirm its active circulation among sheep and goats populations in Morocco, as well as study the risk factors associated with BTV infection. To this end, a total of 1651 samples were randomly collected from 1376 sheep and 275 goats in eight (out of 12) regions of the country between March 2018 and July 2021.These samples were primarily tested using competitive ELISA (c-ELISA). Subsequently, 65% of c-ELISA positives (n = 452) were analyzed by real-time reverse transcription-polymerase chain reaction (RT-qPCR). The results revealed an overall BTV seroprevalence in small ruminants in Morocco of 41.7%, including 42.6% in sheep and 37.5% in goats. The RT-qPCR results showed that the overall BTV viropositivity rate was 46.7%, including 48.1% in sheep and 41.8% in goats. These viro-serological rates varied significantly by age, sex, and breed of the tested animals, husbandry method, season, and geographic origin. This indicates that these parameters constitute risk factors for BTV transmission routes in Morocco. The findings also indicate that goats play a role as reservoirs in maintaining the BTV in Morocco. It appears from this study that bluetongue is endemic in Morocco. The environmental and climate conditions as well as the husbandry methods adopted in the country are particularly favorable for the virus transmission throughout the country.
Collapse
Affiliation(s)
- Soukaina Daif
- Microbiology, Immunology, and Infectious Diseases Unit, Department of Pathology and Veterinary Public Health, Institut Agronomique et Vétérinaire Hassan II, Rabat-Instituts, BP: 6202, Rabat, Morocco
| | - Ikhlass El Berbri
- Microbiology, Immunology, and Infectious Diseases Unit, Department of Pathology and Veterinary Public Health, Institut Agronomique et Vétérinaire Hassan II, Rabat-Instituts, BP: 6202, Rabat, Morocco
| | - Youssef Lhor
- grid.31143.340000 0001 2168 4024National Office of Food Safety (ONSSA), Rabat-Instituts, BP: 6202, Rabat, Morocco
| | - Ouafaa Fassi Fihri
- Microbiology, Immunology, and Infectious Diseases Unit, Department of Pathology and Veterinary Public Health, Institut Agronomique et Vétérinaire Hassan II, Rabat-Instituts, BP: 6202, Rabat, Morocco
| |
Collapse
|
2
|
King S, Flannery J, Batten C, Rajko-Nenow P. Development of real-time RT-qPCR assays for the typing of two novel bluetongue virus genotypes derived from sheeppox vaccine. J Virol Methods 2021; 298:114288. [PMID: 34536487 PMCID: PMC8543067 DOI: 10.1016/j.jviromet.2021.114288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2021] [Revised: 09/10/2021] [Accepted: 09/12/2021] [Indexed: 11/29/2022]
Abstract
Previously, we reported the detection of two novel bluetongue virus (BTV) strains (SPvvvv/02 and SPvvvv/03), possibly representing new BTV genotypes, in a batch of sheeppox vaccine. We developed type-specific RT-qPCR assays (targeting genome segment 2) for these two new BTV strains. The limit of detection of both assays was 10 genome copies/μl and no cross-reactivity with other BTV genotypes was observed. The performance of three other BTV group-specific diagnostic assays was also tested against the putative novel genotypes. RT-qPCR assays targeting BTV segment 9 and 10 detected both strains (SPvvvv/02 and SPvvvv/03) whereas a BTV segment 1 RT-qPCR assay was unable to detect either BTV strain. The work presented here expands upon the current repertoire of RT-qPCR assays for BTV genotype determination.
Collapse
Affiliation(s)
- Simon King
- The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, United Kingdom.
| | - John Flannery
- The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, United Kingdom
| | - Carrie Batten
- The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, United Kingdom
| | - Paulina Rajko-Nenow
- The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, United Kingdom
| |
Collapse
|
3
|
Genomic Analysis Illustrated a Single Introduction and Evolution of Israeli Bluetongue Serotype 8 Virus Population 2008-2019. Microorganisms 2021; 9:microorganisms9091955. [PMID: 34576850 PMCID: PMC8470199 DOI: 10.3390/microorganisms9091955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 09/08/2021] [Accepted: 09/10/2021] [Indexed: 11/17/2022] Open
Abstract
Outbreaks of the European Bluetongue virus (BTV) serotype 8 (BTV-8), which are characterized by activity cycles separated by years of inactivity, may be influenced by genetic changes of the virus or by herd immunity. BTV activity in Israel is characterized by similar dynamics, but differs from European countries in its vector population, environmental conditions, and lack of cattle vaccination against this serotype. Comparison of these two geographical systems and characterization of their epidemiological connection is therefore of high interest in-order to better understand the factors influencing BTV-8 evolution. BTV-8, closely related to the European strain, was introduced to Israel in 2008. It was at the center of BT outbreaks in 2010 and 2015–2016 and thereafter was lastly isolated in Israel in 2019. We performed genetic analyses of twelve BTV-8 Israeli strains isolated between 2008 and 2019 and compared them with published sequences of BTV-8 isolated in other countries. The analysis revealed a single introduction of BTV-8 into Israel and thereafter extensive occurrence of genomic drifts and multiple reassortments with local BTV strains. Comparison of the Israeli and Cypriot BTV-8 from 2015 to 2016 suggests transmission of the virus between the two countries and a separate and parallel development from European or other Israeli BTV-8 strains. The parallel development of other BTV-8 strains was demonstrated by the identification of the Israeli BTV-8 ISR-1194/1/19 strain, which exhibited common origin with reassorted Israeli BTV-8 strains from 2010 and additional reassortment of seven segments. In order to reveal the source of BTV-8 introduction into Israel we performed BEAST analysis which showed that a probable common ancestor for both European and Israeli BTV-8 presumably existed in 2003–2004. In 2019, a possible new introduction occurred in Israel, where a novel BTV-8 strain was detected, sharing ~95% identity by segments 2 and 6 with Nigerian BTV-8NIG1982/07 and European–Middle Eastern strains. The results of the study indicate that Israel and neighboring countries consist a separate environmental and evolutionary system, distinct from European ones.
Collapse
|
4
|
Fakri FZ, Bamouh Z, Elmejdoub S, Elkarhat Z, Tadlaoui K, Chen W, Bu Z, Elharrak M. Long term immunity against Peste Des Petits Ruminants mediated by a recombinant Newcastle disease virus vaccine. Vet Microbiol 2021; 261:109201. [PMID: 34399299 DOI: 10.1016/j.vetmic.2021.109201] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Accepted: 08/03/2021] [Indexed: 11/18/2022]
Abstract
Peste des Petits Ruminants (PPR) is a highly contagious and often fatal disease of sheep and goats. Conventional live vaccines have been successfully used in endemic countries however, there are not completely safe and not allowing differentiation between vaccinated and infected animals (DIVA). In this study, a recombinant Newcastle disease virus (NDV) expressing the hemagglutinin of PPRV (NDV-PPRVH) was evaluated on small ruminants by serology response in sheep and goats, experimental infection in goats and immunity duration in sheep. The NDV-PPRVH vaccine injected twice at 28 days' interval, provided full protection against challenge with a virulent PPR strain in the most sensitive species and induced significant neutralizing antibodies. Immunological response in goats was slightly higher than sheep and the vaccine injected at 108.0 50 % egg infective dose/mL allowed anti-PPRV antibodies that lasted at least 12 months as shown by antibody response monitoring in sheep. The NDV vector presented a limited replication in the host and vaccinated animals remained negative when tested by cELISA based on PPRV nucleoprotein allowing DIVA. This recombinant vaccine appears to be a promising candidate in a free at risk countries and may be an important component of the global strategy for PPR eradication.
Collapse
Affiliation(s)
- F Z Fakri
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| | - Z Bamouh
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| | - S Elmejdoub
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| | - Z Elkarhat
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| | - K Tadlaoui
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| | - W Chen
- Key Laboratory of Veterinary Public Health of Ministry of Agriculture and State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, 150001, China.
| | - Z Bu
- Key Laboratory of Veterinary Public Health of Ministry of Agriculture and State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, 150001, China.
| | - M Elharrak
- Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia, 28810, Morocco.
| |
Collapse
|
5
|
Ries C, Vögtlin A, Hüssy D, Jandt T, Gobet H, Hilbe M, Burgener C, Schweizer L, Häfliger-Speiser S, Beer M, Hoffmann B. Putative Novel Atypical BTV Serotype '36' Identified in Small Ruminants in Switzerland. Viruses 2021; 13:v13050721. [PMID: 33919269 PMCID: PMC8143309 DOI: 10.3390/v13050721] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 04/19/2021] [Accepted: 04/20/2021] [Indexed: 11/16/2022] Open
Abstract
We identified a putative novel atypical BTV serotype '36' in Swiss goat flocks. In the initial flock clinical signs consisting of multifocal purulent dermatitis, facial oedema and fever were observed. Following BTV detection by RT-qPCR, serotyping identified BTV-25 and also a putative novel BTV serotype in several of the affected goats. We successfully propagated the so-called "BTV-36-CH2019" strain in cell culture, developed a specific RT-qPCR targeting Segment 2, and generated the full genome by high-throughput sequencing. Furthermore, we experimentally infected goats with BTV-36-CH2019. Regularly, EDTA blood, serum and diverse swab samples were collected. Throughout the experiment, neither fever nor clinical disease was observed in any of the inoculated goats. Four goats developed BTV viremia, whereas one inoculated goat and the two contact animals remained negative. No viral RNA was detected in the swab samples collected from nose, mouth, eye, and rectum, and thus the experimental infection of goats using this novel BTV serotype delivered no indications for any clinical symptoms or vector-free virus transmission pathways. The subclinical infection of the four goats is in accordance with the reports for other atypical BTVs. However, the clinical signs of the initial goat flock did most likely not result from infection with the novel BTV-36-CH0219.
Collapse
Affiliation(s)
- Christina Ries
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
| | - Andrea Vögtlin
- Institute of Virology and Immunology (IVI), Mittelhäusern, Switzerland and Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; (A.V.); (D.H.); (T.J.); (H.G.)
| | - Daniela Hüssy
- Institute of Virology and Immunology (IVI), Mittelhäusern, Switzerland and Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; (A.V.); (D.H.); (T.J.); (H.G.)
| | - Tabea Jandt
- Institute of Virology and Immunology (IVI), Mittelhäusern, Switzerland and Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; (A.V.); (D.H.); (T.J.); (H.G.)
| | - Hansjörg Gobet
- Institute of Virology and Immunology (IVI), Mittelhäusern, Switzerland and Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; (A.V.); (D.H.); (T.J.); (H.G.)
| | - Monika Hilbe
- Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, 8057 Zürich, Switzerland; (M.H.); (C.B.)
| | - Carole Burgener
- Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, 8057 Zürich, Switzerland; (M.H.); (C.B.)
| | | | | | - Martin Beer
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
| | - Bernd Hoffmann
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
- Correspondence:
| |
Collapse
|
6
|
Rupner RN, VinodhKumar OR, Karthikeyan R, Sinha DK, Singh KP, Dubal ZB, Tamta S, Gupta VK, Singh BR, Malik YS, Dhama K. Bluetongue in India: a systematic review and meta-analysis with emphasis on diagnosis and seroprevalence. Vet Q 2021; 40:229-242. [PMID: 32886028 PMCID: PMC7534259 DOI: 10.1080/01652176.2020.1810356] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Bluetongue (BT) is an infectious viral disease which affects a wide range of ruminants and was first reported in India in 1964. In view of the absence of comprehensive information on the BT status in India, this study presents the seroprevalence on BT in farm animals of India based-on a systematic review and meta-analysis. A systematic review was conducted to identify the published articles (2001–2018) reporting the seroprevalence of BT in sheep, goats, cattle, buffalo, camels, and Mithun (Bos frontalis) from India. From 409 research articles, 71 fulfilled the inclusion criteria and meta-analysis for proportions was carried out targeting the eligible studies. From these, 144 strata level data were extracted with a sample size of 14048 sheep, 14696 goats, 5218 cattle, 2653 buffaloes, 2062 camels, and 222 Mithun. Overall, the analyses showed that the BT seroprevalence of 43% (95% CI: 38–49%) in goats, 39% (95% CI: 33–46%) in sheep, 38% (95% CI: 25–45%) in cattle, 34% (95% CI: 20–51%) in buffaloes, 16% (95% CI: 10–22%) in camels, and 66% (95% CI: 17–95%) in Mithun. Furthermore, the meta-regression analysis suggested that serological tests, geographical region, and sample size were the prime moderators. Meta-analytic study indicates the BT seropositivity in 25.35 million sheep (95% CI: 21.5–29.9), 58 million goats (95% CI: 51.3–66.2), 66.8 million cattle (95% CI: 47.7–86), 37.0 million buffaloes (95% CI: 21.7–55.4), 0.06 million camels (95% CI: 0.04–0.09), and 0.19 million Mithun (95% CI: 0.05–0.28). The findings highlight the variation of BT seropositivity in different geographical regions of India.
Collapse
Affiliation(s)
- Ramkumar N Rupner
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - O R VinodhKumar
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - R Karthikeyan
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - D K Sinha
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - K P Singh
- Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - Z B Dubal
- Division of Veterinary Public Health, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - Shikha Tamta
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - V K Gupta
- CADRAD, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - B R Singh
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - Y S Malik
- Division of Biological Standardisation, ICAR-Indian Veterinary Research Institute, Bareilly, India
| | - K Dhama
- Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India
| |
Collapse
|
7
|
Ries C, Sharav T, Tseren-Ochir EO, Beer M, Hoffmann B. Putative Novel Serotypes '33' and '35' in Clinically Healthy Small Ruminants in Mongolia Expand the Group of Atypical BTV. Viruses 2020; 13:v13010042. [PMID: 33383902 PMCID: PMC7824028 DOI: 10.3390/v13010042] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 12/08/2020] [Accepted: 12/25/2020] [Indexed: 01/08/2023] Open
Abstract
Between 2015 and 2018, we identified the presence of three so-far-unknown Bluetongue virus (BTV) strains (BTV-MNG1/2018, BTV-MNG2/2016, and BTV-MNG3/2016) circulating in clinical healthy sheep and goats in Mongolia. Virus isolation from EDTA blood samples of BTV-MNG1/2018 and BTV-MNG3/2016 was successful on the mammalian cell line BSR using blood collected from surveillance. After experimental inoculation of goats with BTV-MNG2/2016 positive blood as inoculum, we observed viraemia in one goat and with the EDTA blood of the experimental inoculation, the propagation of BTV-MNG2/2016 in cell culture was successful on mammalian cell line BSR as well. However, virus isolation experiments for BTV-MNG2/2016 on KC cells were unsuccessful. Furthermore, we generated the complete coding sequence of all three novel Mongolian strains. For atypical BTV, serotyping via the traditional serum neutralization assay is not trivial. We therefore sorted the ‘putative novel atypical serotypes’ according to their segment-2 sequence identities and their time point of sampling. Hence, the BTV-MNG1/2018 isolate forms the ‘putative novel atypical serotype’ 33, the BTV-MNG3/2016 the ‘putative novel atypical serotype’ 35, whereas the BTV-MNG2/2016 strain belongs to the same putative novel atypical serotype ‘30’ as BTV-XJ1407 from China.
Collapse
Affiliation(s)
- Christina Ries
- Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17943 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
| | - Tumenjargal Sharav
- School of Veterinary Medicine, Mongolian University of Life Sciences, Khan-uul District, Zaisan 17024, Mongolia or (T.S.); (E.-O.T.-O.)
| | - Erdene-Ochir Tseren-Ochir
- School of Veterinary Medicine, Mongolian University of Life Sciences, Khan-uul District, Zaisan 17024, Mongolia or (T.S.); (E.-O.T.-O.)
| | - Martin Beer
- Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17943 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
| | - Bernd Hoffmann
- Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17943 Greifswald-Insel Riems, Germany; (C.R.); (M.B.)
- Correspondence:
| |
Collapse
|
8
|
Ashby M, Rajko-Nenow P, Batten C, Flannery J. Simultaneous Detection of Bluetongue Virus Serotypes Using xMAP Technology. Microorganisms 2020; 8:microorganisms8101564. [PMID: 33050655 PMCID: PMC7650804 DOI: 10.3390/microorganisms8101564] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Revised: 10/08/2020] [Accepted: 10/08/2020] [Indexed: 12/27/2022] Open
Abstract
Bluetongue is an economically important disease of ruminants caused by the bluetongue virus (BTV). BTV is serologically diverse, which complicates vaccination strategies. Rapid identification of the causative BTV serotypes is critical, however, real-time PCR (RT-qPCR) can be costly and time consuming to perform when the circulating serotypes are unknown. The Luminex xMAP technology is a high-throughput platform that uses fluorescent beads to detect multiple targets simultaneously. We utilized existing BTV serotyping RT-qPCR assays for BTV-1 to BTV-24 and adapted them for use with the xMAP platform. The xMAP assay specifically detected all 24 BTV serotypes when testing reference strains. In all BTV-positive samples, the sensitivity of the BTV xMAP was 87.55% whereas the sensitivity of the serotype-specific RT-qPCR was 79.85%. The BTV xMAP assay allowed for the specific detection of BTV serotypes 1-24 at a lower cost than current RT-qPCR assays. Overall, the assay provides a useful novel diagnostic tool, particularly when analyzing large sample sets. The use of the BTV xMAP assay will allow for the rapid assessment of BTV epidemiology and may inform decision-making related to control and prevention measures.
Collapse
|
9
|
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines (Basel) 2020; 8:vaccines8030346. [PMID: 32610561 PMCID: PMC7564706 DOI: 10.3390/vaccines8030346] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Revised: 06/24/2020] [Accepted: 06/27/2020] [Indexed: 12/16/2022] Open
Abstract
The sequence of non-structural protein NS1 of bluetongue virus (BTV), which contains immunodominant CD8+ T cell epitopes, is highly conserved among BTV serotypes, and has therefore become a major tool in the development of a universal BTV vaccine. In this work, we have engineered multiserotype BTV vaccine candidates based on recombinant chimpanzee adenovirus (ChAdOx1) and modified vaccinia virus Ankara (MVA) vectors expressing the NS1 protein of BTV-4 or its truncated form NS1-Nt. A single dose of ChAdOx1-NS1 or ChAdOx1-NS1-Nt induced a moderate CD8+ T cell response and protected IFNAR(-/-) mice against a lethal dose of BTV-4/MOR09, a reassortant strain between BTV-1 and BTV-4, although the animals showed low viremia after infection. Furthermore, IFNAR(-/-) mice immunized with a single dose of ChAdOx1-NS1 were protected after challenge with a lethal dose of BTV-8 in absence of viremia nor clinical signs. Additionally, the heterologous prime-boost ChAdOx1/MVA expressing NS1 or NS1-Nt elicited a robust NS1 specific CD8+ T cell response and protected the animals against BTV-4/MOR09 even 16 weeks after immunization, with undetectable levels of viremia at any time after challenge. Subsequently, the best immunization strategy based on ChAdOx1/MVA-NS1 was assayed in sheep. Non-immunized animals presented fever and viremia levels up to 104 PFU/mL after infection. In contrast, although viremia was detected in immunized sheep, the level of virus in blood was 100 times lower than in non-immunized animals in absence of clinical signs.
Collapse
|
10
|
Flannery J, Frost L, Fay P, Hicks H, Henstock M, Smreczak M, Orłowska A, Rajko-Nenow P, Darpel K, Batten C. BTV-14 Infection in Sheep Elicits Viraemia with Mild Clinical Symptoms. Microorganisms 2020; 8:E892. [PMID: 32545731 PMCID: PMC7355590 DOI: 10.3390/microorganisms8060892] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Revised: 06/09/2020] [Accepted: 06/11/2020] [Indexed: 11/16/2022] Open
Abstract
In 2011, Bluetongue virus serotype 14 (BTV-14) was detected in Russia during routine surveillance, and was subsequently found in a number of European countries. The strain had high sequence similarity to a BTV-14 vaccine strain. We aimed to determine the risk of this BTV-14 strain causing disease in a UK sheep breed. Four Poll Dorset sheep were infected with a Polish isolate of BTV-14 and infection kinetics were monitored over 28 days. BTV RNA was detected in EDTA blood by 4 days post-infection (dpi) and remained detectable at 28 days post-infection (dpi). Peak viraemia occurred at 6 and 7 dpi with Ct values ranging between 24.6 and 27.3 in all infected animals. BTV antibodies were detected by 10 dpi using a commercial ELISA and neutralising antibodies were detected from 10 dpi. BTV was isolated between 6 and 12 dpi. All infected sheep developed mild clinical signs such as reddening of conjunctiva and mucosal membranes, with one sheep demonstrating more overt clinical signs. Two uninoculated control animals remained clinically healthy and did not have detectable BTV RNA or antibodies. The overall mild clinical symptoms caused by this BTV-14 in this highly susceptible sheep breed were in accordance with the asymptomatic infections observed in the affected countries.
Collapse
Affiliation(s)
- John Flannery
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Lorraine Frost
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Petra Fay
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Hayley Hicks
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Mark Henstock
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Marcin Smreczak
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (M.S.); (A.O.)
| | - Anna Orłowska
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (M.S.); (A.O.)
| | - Paulina Rajko-Nenow
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Karin Darpel
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| | - Carrie Batten
- Non-Vesicular Reference Laboratories, The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; (L.F.); (P.F.); (H.H.); (M.H.); (P.R.-N.); (K.D.); (C.B.)
| |
Collapse
|
11
|
Hamdi J, Boumart Z, Daouam S, El Arkam A, Bamouh Z, Jazouli M, Tadlaoui KO, Fihri OF, Gavrilov B, El Harrak M. Development and Evaluation of an Inactivated Lumpy Skin Disease Vaccine for Cattle. Vet Microbiol 2020; 245:108689. [PMID: 32456824 DOI: 10.1016/j.vetmic.2020.108689] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Revised: 04/04/2020] [Accepted: 04/10/2020] [Indexed: 10/24/2022]
Abstract
Lumpy skin disease (LSD) of cattle is caused by a virus within Capripoxvirus genus. It leads to huge economic losses in addition to trade and animal movement limitation. Vaccination is the only economically feasible way to control this vector-borne disease. Only live attenuated vaccines have been used so far and no inactivated vaccine has been developed nor tested in cattle. In this study, we developed an inactivated oily adjuvanted vaccine based on Neethling strain and tested it on cattle. Selected criteria of appreciation were safety, antibody response by Virus Neutralization and protection through challenge. A field trial was also performed in Bulgaria. The vaccine was safe and did not cause any adverse reaction, high level of specific antibodies was obtained starting from day 7 post-vaccination and protection against virulent challenge strain that caused typical disease in control animals was total. Induced protection was similar to that obtained with live vaccine, without any adverse effect. In addition, the field study confirmed safety and efficacy of the vaccine, which did not show any adverse reaction and induced a high level of antibodies for up to one year. General prophylaxis based on inactivated vaccine could be of great benefit in endemic countries or at risk regions.
Collapse
Affiliation(s)
- Jihane Hamdi
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco.
| | - Zineb Boumart
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | - Samira Daouam
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | - Amal El Arkam
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | - Zahra Bamouh
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | - Mohamed Jazouli
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | - Khalid Omari Tadlaoui
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| | | | - Boris Gavrilov
- Biologics Development, Huvepharma, 3A Nikolay Haytov Street, Sofia, 1113, Bulgaria
| | - Mehdi El Harrak
- Research and development Virology, Multi-Chemical Industry, Lot. 157, ZI Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco
| |
Collapse
|
12
|
Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection. Viruses 2020; 12:v12040389. [PMID: 32244509 PMCID: PMC7232183 DOI: 10.3390/v12040389] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 03/25/2020] [Accepted: 03/30/2020] [Indexed: 01/13/2023] Open
Abstract
Peste des petits ruminants (PPR) disease was first confirmed in Tanzania in 2008 in sheep and goats in Ngorongoro District, northern Tanzania, and is now endemic in this area. This study aimed to characterise PPR disease in pastoralist small ruminant flocks in Ngorongoro District. During June 2015, 33 PPR-like disease reports were investigated in different parts of the district, using semi-structured interviews, clinical examinations, PPR virus rapid detection test (PPRV-RDT), and laboratory analysis. Ten flocks were confirmed as PPRV infected by PPRV-RDT and/or real-time reverse transcription-polymerase chain reaction (RT-qPCR), and two flocks were co-infected with bluetongue virus (BTV), confirmed by RT-qPCR. Phylogenetic analysis of six partial N gene sequences showed that the PPR viruses clustered with recent lineage III Tanzanian viruses, and grouped with Ugandan, Kenyan and Democratic Republic of Congo isolates. No PPR-like disease was reported in wildlife. There was considerable variation in clinical syndromes between flocks: some showed a full range of PPR signs, while others were predominantly respiratory, diarrhoea, or oro-nasal syndromes, which were associated with different local disease names (olodua-a term for rinderpest, olkipiei-lung disease, oloirobi-fever, enkorotik-diarrhoea). BTV co-infection was associated with severe oro-nasal lesions. This clinical variability makes the field diagnosis of PPR challenging, highlighting the importance of access to pen-side antigen tests and multiplex assays to support improved surveillance and targeting of control activities for PPR eradication.
Collapse
|